Patents-Review.com
ClassID:

110827 ⎘

C12N2760/16171 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus A, i.e. influenza A virus Demonstrated effect

Recent Application in this class:
#1
20260124292
2026-05-07

MULTIEPITOPE UNIVERSAL INFLUENZA VACCINE

 #2
20260083834
2026-03-26

CsgA-DERIVED NANOSTRUCTURES AND USES THEREOF FOR ANTIGEN DELIVERY

 #3
20260077030
2026-03-19

MEMBRANE VESICLES COMPRISING MULTIPLE INFLUENZA ANTIGENS FOR VACCINES

 #4
20260071224
2026-03-12

ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN EXPRESSION

 #5
20260061045
2026-03-05

METHOD FOR PREVENTION AND TREATMENT OF VIRAL DISEASE

 #6
20260007735
2026-01-08

MRNA ENCODING INFLUENZA VIRUS-LIKE PARTICLE

 #7
20260001918
2026-01-01

INFLUENZA VIRUS VACCINES AND USES THEREOF

 #8
20250325650
2025-10-23

DEOPTIMIZED INFLUENZA VIRUSES AND METHODS OF TREATING CANCER

 #9
20250325649
2025-10-23

POLYPEPTIDE FRAGMENTS, IMMUNOGENIC COMPOSITION AGAINST INFLUENZA VIRUS, AND IMPLEMENTATIONS THEREOF

 #10
20250288661
2025-09-18

AVIAN INFLUENZA VIRUS VACCINES

 #11
20250249087
2025-08-07

CONSTRUCTION OF NOVEL HUMAN INFLUENZA VIRUS VACCINE AND APPLICATION

 #12
20250248947
2025-08-07

TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION

 #13
20250121049
2025-04-17

INFLUENZA VIRUS HEMAGGLUTININ PROTEINS AND USES THEREOF

 #14
20250090649
2025-03-20

INFLUENZA VIRUS MUTANTS AND USES THEREFOR

 #15
20250057935
2025-02-20

ADENOVIRAL VECTOR SYSTEM FOR GENE DELIVERY

 #16
20250032602
2025-01-30

FORMULATIONS FOR SMALL INTESTINAL DELIVERY

 #17
20240342268
2024-10-17

RECOMBINANT VIRUS CONTAINING DEGRON, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

 #18
20240335524
2024-10-10

Influenza virus hemagglutinin proteins and uses thereof

 #19
20240269257
2024-08-15

INORGANIC POLYATOMIC OXYANIONS FOR PROTECTING AGAINST ANTIGENIC DAMAGE DURING PATHOGEN INACTIVATION FOR VACCINE PRODUCTION

 #20
20240226012
2024-07-11

NOVEL MULTIVALENT NANOPARTICLE-BASED VACCINES

 #21
20240216502
2024-07-04

Universal vaccine platform

 #22
20240189415
2024-06-13

GRAPHENE OXIDE NANOPARTICLES AND METHODS OF USE FOR STIMULATING IMMUNE RESPONSES

 #23
20240180848
2024-06-06

TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION

 #24
20240084267
2024-03-14

COMPOSITIONS AND METHODS FOR THE GENETIC MANIPULATION OF THE INFLUENZA VIRUS

 #25
20230372466
2023-11-23

UNIVERSAL MAMMALIAN INFLUENZA VACCINE

 #26
20230348864
2023-11-02

INFLUENZA VIRUSES WITH MUTANT PB2 GENE SEGMENT AS LIVE ATTENUATED VACCINES

 #27
20230346910
2023-11-02

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

 #28
20230313207
2023-10-05

ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN EXPRESSION

 #29
20230310575
2023-10-05

Hemagglutinin Modifications for Improved Influenza Vaccine Production

 #30
20230193311
2023-06-22

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

 #31
20230174586
2023-06-08

STRAIN DIS-DERIVED RECOMBINANT VACCINIA VIRUS HAVING NOVEL INFLUENZA VIRUS-DERIVED HEMAGGLUTININ PROTEIN GENE

 #32
20230147673
2023-05-11

RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF

 #33
20230099147
2023-03-30

Immunogenic compositions against influenza

 #34
20230058789
2023-02-23

SARS-COV-2 CHIMERIC VLP VACCINE COMPOSITION, EXPRESSING VECTOR AND USE THEREOF

 #35
20220409719
2022-12-29

Influenza virus mutants and uses therefor

 #36
20220380410
2022-12-01

Live Attenuated Universal Influenza Virus Vaccines, Methods and Uses Thereof

 #37
20220370594
2022-11-24

Whole avian-origin reverse genetic system and its use in producing H7N9 subtype avian influenza vaccine

 #38
20220347295
2022-11-03

Vaccine delivery method

 #39
20220307040
2022-09-29

Artificial nucleic acid molecules for improved protein expression

 #40
20220305131
2022-09-29

MODIFIED VIRUS-LIKE PARTICLES OF CMV

 #41
20220288188
2022-09-15

Adenoviral vector system for gene delivery

 #42
20220257749
2022-08-18

Influenza virus hemagglutinin proteins and uses thereof

 #43
20220242918
2022-08-04

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

 #44
20220241395
2022-08-04

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

 #45
20220233700
2022-07-28

PHARMACEUTICAL COMPOSITION CONTAINING STABILIZED NUCLEIC ACID ADJUVANT

 #46
20220226463
2022-07-21

RECOMBINANT NON-STRUCTURAL PROTEIN 1, RECOMBINANT INFLUENZA VIRUS AND IMMUNOLOGICAL COMPOSITION INCLUDING THE SAME, AND METHOD OF TREATING OR PREVENTING DISEASE OR CONDITION CAUSED BY OR ASSOCIATED WITH INFLUENZA VIRUS

 #47
20220211841
2022-07-07

NUCLEIC ACID BASED COMBINATION VACCINES

 #48
20220145317
2022-05-12

INFLUENZA VIRUS-LIKE PARTICLE PRODUCTION IN PLANTS

 #49
20220105171
2022-04-07

Materials and methods for respiratory disease control in canines

 #50
20220090092
2022-03-24

Artificial nucleic acid molecules for improved protein expression

 #51
20220054419
2022-02-24

Multivalent nanoparticle-based vaccines

 #52
20220025339
2022-01-27

Mutations that confer genetic stability to additional genes in influenza viruses

 #53
20220009970
2022-01-13

Immunogenic composition against avian influenza virus H5 subtype

 #54
20220002737
2022-01-06

Artificial nucleic acid molecules for improved protein expression

 #55
20210330785
2021-10-28

Universal vaccine platform

 #56
20210299249
2021-09-30

Recombinant multivalent influenza viruses

 #57
20210260179
2021-08-26

MOSAIC INFLUENZA VIRUS HEMAGGLUTININ POLYPEPTIDES AND USES THEREOF

 #58
20210225457
2021-07-22

METHODS FOR GENERATING PAN-EPITOPIC IMMUNOGENS OF INFLUENZA H3 VIRUS, COMPOSITIONS AND METHODS OF USE THEREOF

 #59
20210196812
2021-07-01

Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production

 #60
20210015916
2021-01-21

Vaccine delivery method

 #61
20210000947
2021-01-07

Mucosal adjuvants and delivery systems

 #62
20200397889
2020-12-24

Influenza peptides and compositions

 #63
20200377908
2020-12-03

Parainfluenza virus 5 based vaccines

 #64
20200360507
2020-11-19

Influenza vaccine

 #65
20200263143
2020-08-20

Influenza viruses with mutant PB2 gene segment as live attenuated vaccines

 #66
20200255849
2020-08-13

Influenza virus-like particle production in plants

 #67
20200254085
2020-08-13

Immunogenic compositions against influenza

 #68
20200223892
2020-07-16

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

 #69
20200155699
2020-05-21

Modified virus-like particles of CMV

 #70
20200108094
2020-04-09

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

 #71
20200085943
2020-03-19

Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen

 #72
20200061182
2020-02-27

Influenza virus mutants and uses therefor

 #73
20200046826
2020-02-13

Methods and compositions for immunization against virus

 #74
20190336596
2019-11-07

Universal vaccine platform

 #75
20190321459
2019-10-24

Universal mammalian influenza vaccine

 #76
20190321458
2019-10-24

Formulation for administration of RNA

 #77
20190314496
2019-10-17

Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant

 #78
20190314488
2019-10-17

Materials and methods for respiratory disease control in canines

 #79
20190314485
2019-10-17

Influenza virus hemagglutinin proteins and uses thereof

 #80
20190231869
2019-08-01

Mucosal adjuvants and delivery systems

 #81
20190201520
2019-07-04

Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production

 #82
20190201519
2019-07-04

Influenza peptides and compositions

 #83
20190177739
2019-06-13

Recombinant influenza virus-like particles (VLPS) produced in transgenic plants

 #84
20190092820
2019-03-28

Computationally optimized broadly reactive antigens for human and avian H5N1 influenza

 #85
20190062713
2019-02-28

Highly efficient influenza matrix (M1) proteins

 #86
20190060441
2019-02-28

Influenza virus mutants and uses therefor

 #87
20190054162
2019-02-21

Influenza vaccine

 #88
20190008949
2019-01-10

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA

 #89
20190000968
2019-01-03

Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same

 #90
20190000961
2019-01-03

Vaccine compositions

 #91
20180369363
2018-12-27

Genetically engineered swine influenza virus and uses thereof

 #92
20180298063
2018-10-18

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

 #93
20180271972
2018-09-27

Characterization of influenza vaccines

 #94
20180245054
2018-08-30

Mutations that confer genetic stability to additional genes in influenza viruses

 #95
20180245052
2018-08-30

Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases

 #96
20180223261
2018-08-09

Attenuated influenza vaccines and uses thereof

 #97
20180185470
2018-07-05

Peptide sequences and compositions

 #98
20180169217
2018-06-21

Materials and methods for respiratory disease control in canines

 #99
20180147277
2018-05-31

Peptide sequences and compositions

 #100
20180080044
2018-03-22

Swine influenza vaccine

 #101
20180080043
2018-03-22

EHV insertion site ORF70

 #102
20180044687
2018-02-15

Artificial nucleic acid molecules for improved protein expression

 #103
20180021424
2018-01-25

Liposomal adjuvant compositions

 #104
20180021258
2018-01-25

Multivalent nanoparticle-based vaccines

 #105
20180008702
2018-01-11

ADJUVANT COMPOSITION CONTAINING AT LEAST ONE INFLUENZA VIRUS NEUTRALIZING AND BINDING MOLECULE AND VACCINE COMPOSITION CONTAINING SAME

 #106
20170327845
2017-11-16

PIV5 as an oncolytic agent

 #107
20170312371
2017-11-02

Modified virus-like particles of CMV

 #108
20170298387
2017-10-19

Virus-based expression vectors and uses thereof

 #109
20170253861
2017-09-07

Highly efficient influenza matrix (M1) proteins

 #110
20170252430
2017-09-07

Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant

 #111
20170246289
2017-08-31

Method of quickly producing antibodies against avian influenza and maintain antibody titer of duck

 #112
20170239348
2017-08-24

Adjuvant composition containing citrulline

 #113
20170232097
2017-08-17

Live attenuated viral vaccine created by self-attenuation with species-specific artificial MicroRNA

 #114
20170232096
2017-08-17

Vaccine in the form of a recombinant sero type 9 avian adenovirus vector

 #115
20170224807
2017-08-10

Newcastle disease virus vectored avian vaccines

 #116
20170202958
2017-07-20

VACCINE DELIVERY METHOD

 #117
20170202947
2017-07-20

Computationally optimized broadly reactive antigens for influenza

 #118
20170165352
2017-06-15

Influenza virus hemagglutinin protein as a vaccine antigen

 #119
20170151324
2017-06-01

Genetically engineered swine influenza virus and uses thereof

 #120
20170151323
2017-06-01

Recombinant swine influenza virus and uses thereof

 #121
20170143823
2017-05-25

Mucosal adjuvants and delivery systems

 #122
20170107262
2017-04-20

Computationally optimized broadly reactive antigens for human and avian H5N1 influenza

 #123
20170088848
2017-03-30

Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin

 #124
20170067080
2017-03-09

Parainfluenza virus 5 based vaccines

 #125
20170065715
2017-03-09

Vaccine compositions comprising a saponin adjuvant

 #126
20170049877
2017-02-23

West Nile Virus vaccine

 #127
20170037379
2017-02-09

Chimeric viruses presenting non-native surface proteins and uses thereof

 #128
20170028053
2017-02-02

Peptide sequences and compositions

 #129
20170021008
2017-01-26

Vaccine compositions

 #130
20170007692
2017-01-12

Immunomodulatory compounds

 #131
20170000877
2017-01-05

Monovalent H5 vaccine

 #132
20160362455
2016-12-15

Influenza virus vaccines and uses thereof

 #133
20160279227
2016-09-29

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

 #134
20160256537
2016-09-08

Influenza vaccine

 #135
20160228535
2016-08-11

Influenza virus mutants and uses therefor

 #136
20160228534
2016-08-11

Influenza virus mutants and uses therefor

 #137
20160228533
2016-08-11

Use of EGFR pathway inhibitors to increase immune responses to antigens

 #138
20160185826
2016-06-30

VIRUS-LIKE PARTICLE VACCINES

 #139
20160151480
2016-06-02

Universal influenza vaccine

 #140
20160136262
2016-05-19

Influenza virus vaccines and uses thereof

 #141
20160136261
2016-05-19

Live attenuated vaccines for influenza viruses

 #142
20160136260
2016-05-19

Attenuated influenza vaccines and uses thereof

 #143
20160122777
2016-05-05

Influenza virus-like particle production in plants

 #144
20160074504
2016-03-17

Nanoemulsion influenza vaccine

 #145
20150368621
2015-12-24

Mutations that confer genetic stability to additional genes in influenza viruses

 #146
20150366796
2015-12-24

Intradermal delivery of immunological compositions comprising toll-like receptor 7 agonists

 #147
20150335728
2015-11-26

Methods and compositions for immunization against virus

 #148
20150328305
2015-11-19

Viral immunogenic compositions

 #149
20150307851
2015-10-29

Influenza viruses with mutant PB2 segment as live attenuated vaccines

 #150
20150307849
2015-10-29

Highly efficient influenza matrix (M1) proteins

 #151
20150297710
2015-10-22

Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase

 #152
20150283224
2015-10-08

Influenza vaccines

 #153
20150273049
2015-10-01

Genetically engineered swine influenza virus and uses thereof

 #154
20150247128
2015-09-03

MDCK-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells

 #155
20150216967
2015-08-06

IC31 nanoparticles

 #156
20150132330
2015-05-14

Influenza virus vaccines and uses thereof

 #157
20150118264
2015-04-30

PHARMACEUTICAL COMPOSITION COMPRISING A POLYMERIC CARRIER CARGO COMPLEX AND AT LEAST ONE PROTEIN OR PEPTIDE ANTIGEN

 #158
20150110832
2015-04-23

Deletion mutants of flagellin and methods of use

 #159
20150099859
2015-04-09

Deletion mutants of flagellin and methods of use

 #160
20150056235
2015-02-26

Materials and methods for respiratory disease control in canines

 #161
20140370050
2014-12-18

PIV5 as oncolytic agent

 #162
20140370041
2014-12-18

Compositions and methods for treating influenza

 #163
20140357845
2014-12-04

Influenza virus vaccines and uses thereof

 #164
20140356388
2014-12-04

Vaccine—screening method

 #165
20140348906
2014-11-27

Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes

 #166
20140234358
2014-08-21

Newcastle disease virus vectored avian vaccines

 #167
20130230552
2013-09-05

Influenza viruses with mutant PB2 gene segment as live attenuated vaccines

 #168
20130039973
2013-02-14

Viral Immunogenic Compositions

 #169
20130039938
2013-02-14

Highly efficient influenza matrix (M1) proteins

 #170
20130034581
2013-02-07

Genetically engineered swine influenza virus and uses thereof

 #171
20120308618
2012-12-06

1C31 nanoparticles

 #172
20120258134
2012-10-11

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

 #173
20120244600
2012-09-27

Swine influenza hemagglutinin variants

 #174
20120219584
2012-08-30

PROTECTION AGAINST PANDEMIC AND SEASONAL STRAINS OF INFLUENZA

 #175
20120219575
2012-08-30

Peptide sequences and compositions

 #176
20120195960
2012-08-02

Post-exposure therapy of influenza A infections

 #177
20120122185
2012-05-17

Chimeric viruses presenting non-native surface proteins and uses thereof

 #178
20120114746
2012-05-10

Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes

 #179
20120034264
2012-02-09

INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS

 #180
20120003263
2012-01-05

RECOMBINANT RACCOON POX VIRUS VACCINE AGAINST HIGHLY PATHOGENIC AVIAN INFLUENZA

 #181
20110311586
2011-12-22

Materials and methods for respiratory disease control in canines

 #182
20110243987
2011-10-06

Influenza vaccine

 #183
20110206758
2011-08-25

Vaccine compositions comprising a saponin adjuvant

 #184
20110159033
2011-06-30

West Nile Virus vaccine

 #185
20110150926
2011-06-23

INFLUENZA VACCINES

 #186
20110135680
2011-06-09

Deletion mutants of flagellin and methods of use

 #187
20110123559
2011-05-26

Swine influenza hemagglutinin variants

 #188
20110117128
2011-05-19

Compositions that Include Hemagglutinin, Methods of Making and Methods of Use Thereof

 #189
20110052618
2011-03-03

Influenza hemagglutinin and neuraminidase variants

 #190
20110027314
2011-02-03

Influenza Vaccines Containing Hemagglutinin and Matrix Proteins

 #191
20110008295
2011-01-13

Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof

 #192
20110003884
2011-01-06

Viral Vectors and Methods of Use

 #193
20100310604
2010-12-09

RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ

 #194
20100255029
2010-10-07

Newcastle disease virus vectored avian vaccines

 #195
20100247571
2010-09-30

Methods and compositions for immunization against virus

 #196
20100233785
2010-09-16

NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES

 #197
20100158942
2010-06-24

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

 #198
20100047275
2010-02-25

Peptide sequences and compositions

 #199
20100008945
2010-01-14

Recombinant Newcastle Disease Virus Expressing H5 Hemagglutinin of Avian Influenza Virus

 #200
20090304799
2009-12-10

Nanoemulsion influenza vaccine

 #201
20090203114
2009-08-13

Methods for the propagation of modified influenza viruses in embryonated eggs

 #202
20090175909
2009-07-09

Influenza hemagglutinin and neuraminidase variants

 #203
20090136530
2009-05-28

Influenza hemagglutinin and neuraminidase variants

 #204
20090053264
2009-02-26

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

 #205
20090017067
2009-01-15

Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase

 #206
20090010962
2009-01-08

Genetically engineered swine influenza virus and uses thereof

 #207
20080279926
2008-11-13

Vaccine Compositions Comprising a Saponin Adjuvant

 #208
20080075736
2008-03-27

Materials and methods for respiratory disease control in canines

 #209
20070253982
2007-11-01

Compositions that include hemagglutinin

 #210
20070224205
2007-09-27

Compositions that include hemagglutinin, methods of making and methods of use thereof

 #211
20060008473
2006-01-12

Influenza hemagglutinin and neuraminidase variants

 #212
20050287172
2005-12-29

Influenza hemagglutinin and neuraminidase variants

 #213
20050054074
2005-03-10

Methods and interferon deficient substrates for the propagation of viruses